Skip to main content
Have a personal or library account? Click to login
Novel patterns of the Epstein-Barr nuclear antigen (EBNA-1) V-Val subtype in EBV-associated nasopharyngeal carcinoma from Vietnam Cover

Novel patterns of the Epstein-Barr nuclear antigen (EBNA-1) V-Val subtype in EBV-associated nasopharyngeal carcinoma from Vietnam

By: ,  ,   and    
Open Access
|Aug 2019

Figures & Tables

Figure 1

Schematic of the EBNA-1 gene and position of primers aligned with B95-8 strain (V10555). Primer 1: EBNA-1-1; primer 2: EBNA-1-2; primer 3: EBNA-1-3 and primer 4: EBNA-1-4.

Table 1

The sequence of primers used in two stages nested-PCR.

StagePrimersSequencesTemperature
1EBNA-1-15'-TAG TCA GTC ATC ATC ATC CG-3'55 °C
EBNA-1-25'-GGG ATT TAT TCT TTA GTG CG-3'
2EBNA-1-35'-GCC ATT TTT CCA CCC TGT AG-3'
EBNA-1-45'-ATT GAG GGC GTC TCC TAA CA-3'60 °C
Figure 2

Electrophoresis of nested-PCR products of the represented NPC biopsy samples. T91, T92, T93, T94, T95, T96: clinical biopsy samples; N: negative control; MW: molecular weight 100 bp.

Figure 3

Represented sequence identification of EBNA-1 subtype based on the amino acid at position 487. A) T91: V-Val subtype; B) V-Leu subtype; C) P-Thr subtype; D) P-Ala subtype.

Table 2

Nucleotide and amino acid substitution in EBNA-1 C-terminal domain compared to B95-8B sequence.

B95-8109408109409109410109423109424109425109444109445109446109447109448109449109453109454109455109507109508109509109519109520109521
487492499500502520524
GCTAGTGACGAAACTCTAACT
AlaSerAspGluThrLeuThr
T5TGACT
Val*Glu*Asn+Ile
T6TGACT
Val*Glu*Asn+Ile
T77TGAcT
Val*Glu*Asn+Ile
T70TGAcT
Val*Glu*Asn+Ile
T75TTGAcT
ValCysGlu*Asn+Ile
B95-8109531109532109533109534109535109536109546109547109548109606109607109608109702109703109704109711109712109713109729109730109731
528529533553585588594
ATTCCACTTCCGACAGCTAGG
IleProLeuProThrAlaArg
T5GAAA
Val*Ile+**Lys
T6GAATA
Val*Ile+Ile*Lys
T77AATCA
*Gin*+IleProLys
T70GAATCA
Val*Ile+IleProLys
T75GAATCA
Val*Ile+IleProLys

[i] NB: The top four rows correspond to the nucleotide, amino acid position, nucleotide and amino acid of B95-8 prototype sequence. In each row, the upper character denoted the nucleotide that is different to the B95-8 prototype sequence. Conversely, the dot (•) denotes the same nucleotide compared to the referent sequence. The characters below indicate the amino acid written in the three letter code that is different to the reference sequence, while the asterisk (*) indicates the unchanged amino acid, and the plus sign (+) indicates the silent amino acid changes.

Figure 4

Represented nucleotide substitution consensus changes indicated by T5. Amino acid at position: A) codon 497; B) codon 499; C) codon 502; D) codon 520; E) codon 524; F) codon 553; G) codon 594.

Figure 5

Represented nucleotide/amino acid additional changes: A) codon 585 by T6; B) codons 528 and 529 by T77; C) codon 588 by T77; D) codon 492 by T75.

Table 3

The comparison between the patterns of the current study and the previous sequences.

Codon487492499502520524528529533553585588594
Pattern 1T5ValSerGluAsnLeuIleValProIleProThrAlaLys
Pattern 2T6···Ile
Pattern 3T77IleGinLeuIlePro
Pattern 4T70IlePro
Pattern 5T75•/CysIlePro
Study 1GC4
Study 2Thr

[i] NB: The EBNA-1 sequence variants in study 1 [19] and study 2 [16]. The dot (•) denotes the same nucleotide compared to each of the sequences.

DOI: https://doi.org/10.2478/bjmg-2019-0011 | Journal eISSN: 2199-5761 (formerly 1311-0160) | Journal ISSN: 1311-0160
Language: English
Page range: 61 - 68
Published on: Aug 28, 2019
Published by: Macedonian Academy of Sciences and Arts
In partnership with: Paradigm Publishing Services

© 2019 LD Thuan, ND Kha, NT Minh, LHA Thuy, published by Macedonian Academy of Sciences and Arts
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.